Pre-existing conditions.

This large survey of nearly 5500 patients treated for cancer demonstrates that two-thirds have at least one comorbid condition, which in turn makes them significantly less likely to be offered clinical trial participation. To improve the power and applicability of cancer trials, the authors suggest including real-world patients. | Unger, JAMA Oncol 2019